SMTL ID : 2xyd.2 (1 other biounit)

human Angiotenisn converting enzyme N-domain in complex with Phosphinic tripeptide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.15 Å

Oligo State

monomer

Ligands

1 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-FUC.1: 5 residues within 4Å: Chain A: E.161, T.478, N.480, T.482, H.483 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:T.478, A:T.482

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.2: 5 residues within 4Å: Chain A: N.45, T.47, E.49, N.50, R.53 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG-BMA.3: 5 residues within 4Å: Chain A: N.416, E.522, G.523, P.524, Q.527 No protein-ligand interaction detected (PLIP)

1 x 3ES: [(2S)-2-({3-[HYDROXYL(2-PHENYL-(1R)-1-{[(BENZYLOXY)[(2S)-2-({3-[HYDROXYL(2-PHENYL-(1R)-1-CARBONYL]-AMINO}ETHYL)PHOSPHINYL]-2-[(3-PHENYLISOXAZOL-5-YL)METHYL]-1-OXO-PROPYL}AMINO)-3-(4-HYDROXY-PHENYL)(Non-covalent)

3ES.4: 24 residues within 4Å: Chain A: Q.259, H.331, A.332, S.333, A.334, T.358, H.361, E.362, H.365, Y.369, H.388, E.389, D.393, F.435, K.489, F.490, H.491, T.496, Y.498, R.500, Y.501, F.505 Ligands: ZN.5, PEG.9 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:H.388, A:F.435, A:F.435, A:F.490, A:F.490, A:T.496, A:Y.501 Hydrogen bonds: A:Q.259, A:A.334 Water bridges: A:E.389, A:Y.501 Salt bridges: A:H.331, A:K.489, A:H.491 pi-Stacking: A:H.361, A:H.388, A:F.505

1 x ZN: ZINC ION(Non-covalent)

ZN.5: 4 residues within 4Å: Chain A: H.361, H.365, E.389 Ligands: 3ES.4 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.361, A:H.365, A:E.389

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.6: 4 residues within 4Å: Chain A: Y.202, P.385, P.497, R.500 Ligand excluded by PLIP

1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)

PG4.7: 5 residues within 4Å: Chain A: Q.286, G.287, W.288, H.292 Ligands: P6G.8 No protein-ligand interaction detected (PLIP)

1 x P6G: HEXAETHYLENE GLYCOL(Non-functional Binders)

P6G.8: 4 residues within 4Å: Chain A: R.295, V.296, I.408 Ligands: PG4.7 No protein-ligand interaction detected (PLIP)

1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.9: 4 residues within 4Å: Chain A: D.43, A.334, W.335 Ligands: 3ES.4 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Akif, M. et al., Novel Mechanism of Inhibition of Human Angiotensin-I-Converting Enzyme (Ace) by a Highly Specific Phosphinic Tripeptide. Biochem.J. (2011)

Release Date

2011-05-11

Peptides

ANGIOTENSIN-CONVERTING ENZYME: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

ANGIOTENSIN-CONVERTING ENZYME

Related Entries With Identical Sequence